Alterity Therapeutics Limited (PRNAF) Financials

PRNAF Assets vs Liabilities

DateAssetsLiabilities
Dec. 31, 2025 38.0 million 1.8 million
June 30, 2025 30.3 million 2.4 million
March 31, 2025 ? ?
Dec. 31, 2024 6.6 million 1.7 million

PRNAF Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 -3.5 million ?
June 30, 2025 -1.5 million ?
March 31, 2025 -453829 ?
Dec. 31, 2024 -3.1 million ?

PRNAF Net Income

No data available :(

PRNAF Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 32.8 million 87410 43705
June 30, 2025 26.7 million 58228 102230
March 31, 2025 - - -
Dec. 31, 2024 2.8 million 26792 65760

PRNAF Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 6.8 billion
June 30, 2025 4.9 billion
March 31, 2025 ?
Dec. 31, 2024 3.3 billion

PRNAF Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 7.1 million 5.2 million 3.4 million -
June 30, 2025 - 2.9 million 713784 -110544
March 31, 2025 - - - -
Dec. 31, 2024 - 3.6 million 2.1 million 208905

PRNAF Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 - 38651
June 30, 2025 1.3 million 21019
March 31, 2025 - -
Dec. 31, 2024 997881 39518

PRNAF

Price: $0.06

52 week price:
0.00
0.70

Earnings Per Share: -0.01 USD

P/E Ratio: -1.01

Exchange: PNK

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 12.0 million

Links: